Yingjie Nie

Correction: Ansofaxine hydrochloride inhibits tumor growth and enhances anti-TNFR2 in murine colon cancer model

Qianyu Jing, Quan Wan, Yujie Nie, Junqian Luo et autres

Colon cancer (CRC) is the fourth deadliest cancer worldwide, killing hundreds of thousands of people each year (1). At the same time, the mental health of patients is also attracting more and more attention, with the occurrence of depression in cancer patients …

cn (code pays fourni par la source)

A bibliometric analysis of artificial intelligence in ovarian cancer research from 2006 to 2025

Jiujie He, W Zhou, Yujun He, Yingjie Nie et autres

BACKGROUND: Ovarian cancer is a gynecological malignancy associated with high mortality and poses significant clinical challenges in early diagnosis and precision treatment. Although the rapid advancement of artificial intelligence (AI) has introduced novel approaches to this field, a comprehensive bibliometric overview remains …

cn (code pays fourni par la source)

Investigating the efficacy of propranolol in treating chronic stress combined with colorectal cancer in mice and its antitumor potential

Shengwen Zhou, Linjian Xia, Liming Zhao, Jia Song et autres

cn, hk (code pays fourni par la source)

lncRNA FBXL19-AS1 Regulates Osteosarcoma Cell Proliferation, Migration and Invasion by Sponging miR-346 [Retraction]

Runsang Pan, Zhixu He, Wanyuan Ruan, Sun Li et autres

[This retracts the article DOI: 10.2147/OTT.S160963.].

Environmental enrichment suppresses colorectal cancer progression with comorbid depression by modulating the immunosuppressive tumor microenvironment

Jia Song, Liming Zhao, Shengwen Zhou, Quan Wan et autres

cn (code pays fourni par la source)

Global burden of ovarian cancer attributable to high BMI, 1990–2021: spatiotemporal trends, risk factors, frontier analysis, and projections to 2036 based on GBD 2021 study

Jingjing He, Yujun He, Yingjie Nie, Hua Qiu et autres

BACKGROUND: Despite the well-established link between elevated body mass index (BMI) and ovarian cancer, comprehensive global assessments of the attributable burden remain scarce. Using the Global Burden of Disease (GBD) 2021 database, we quantified deaths and disability-adjusted life years (DALYs) from ovarian …

cn (code pays fourni par la source)

Anti-TNFR2 Antibody and HMGN1 Combined with TIL Cell Therapy Inhibits Colorectal Cancer Progression by Enhancing Immune Response

Hang Lv, Yujie Nie, Huan Gui, Haohua Yuan et autres

cn (code pays fourni par la source)

PPDPF-mediated regulation of BCAA metabolism enhances mTORC1 activity and drives cholangiocarcinoma progression

Zhi Li, Yidi Guan, Jie Gao, Lan Zhu et autres

cn (code pays fourni par la source)

Intratumoral injection of R848 and poly(I:C) synergistically promoted antitumor immune responses by reprogramming macrophage polarization and activating DCs in lung cancer

Shuanghui Chen, Linzhao Li, Haohua Yuan, Huan Gui et autres

INTRODUCTION: Immunotherapy has rapidly become a primary treatment option for many lung cancer patients because of its success in treating this prevalent and deadly disease. However, the success of immunotherapy relies on overcoming the immunosuppressive tumor microenvironment, making remodeling this environment a …

cn (code pays fourni par la source)

Ansofaxine suppressed NSCLC progression by increasing sensitization to combination immunotherapy

Huan Gui, Yujie Nie, Haohua Yuan, Mengjiao Wang et autres

cn (code pays fourni par la source)

Lactic Acidosis as a Potential Mechanism of Unexpected Cardiac Toxicity following Chemoradiation Therapy for Non-Small Cell Lung Cancer

Kristian Holgersson, Yingjie Nie, Reinhard W. Schulte

The combination of a PTP1B inhibitor, TNFR2 blocker, and PD‑1 antibody suppresses the progression of non‑small cell lung cancer tumors by enhancing immunocompetence

Huan Gui, Yujie Nie, Haohua Yuan, Qianyu Jing et autres

Lung cancer is increasingly recognized as a leading cause of cancer‑related mortality. Immunotherapy has emerged as a promising therapeutic approach for lung cancer, particularly non‑small cell lung cancer (NSCLC). Nonetheless, the response rate to programmed cell death 1 (PD‑1) inhibitors remains less …

cn (code pays fourni par la source)